Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Delayed Quote USD

Vigil Neuroscience, Inc. (VIGL)

Compare
1.7100
+0.2000
+(13.25%)
At close: April 17 at 4:00:01 PM EDT
1.7600
+0.05
+(2.92%)
After hours: April 17 at 6:11:55 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
89,683
89,683
88,866
68,884
42,409
Operating Income
-89,683
-89,683
-88,866
-68,884
-42,409
Net Non Operating Interest Income Expense
5,418
5,418
6,241
623
3
Other Income Expense
9
9
-13
-44
-877
Pretax Income
-84,256
-84,256
-82,638
-68,305
-43,283
Net Income Common Stockholders
-84,256
-84,256
-82,638
-68,305
-43,283
Diluted NI Available to Com Stockholders
-84,256
-84,256
-82,638
-68,305
-43,283
Basic EPS
-2.07
--
-2.13
-2.16
-1.53
Diluted EPS
-2.07
--
-2.13
-2.16
-1.53
Basic Average Shares
40,668.4440
--
38,712.2070
31,685.1250
28,263.9630
Diluted Average Shares
40,668.4440
--
38,712.2070
31,685.1250
28,263.9630
Total Operating Income as Reported
-89,683
-89,683
-88,866
-68,884
-42,409
Total Expenses
89,683
89,683
88,866
68,884
42,409
Net Income from Continuing & Discontinued Operation
-84,256
-84,256
-82,638
-68,305
-43,283
Normalized Income
-84,256
-84,256
-82,638
-68,305
-43,283
Interest Income
5,418
5,418
6,241
623
3
Net Interest Income
5,418
5,418
6,241
623
3
EBIT
-89,683
-89,683
-88,866
-68,884
-42,409
EBITDA
-89,230
-89,230
-88,467
-68,806
-42,381
Reconciled Depreciation
453
453
399
78
28
Net Income from Continuing Operation Net Minority Interest
-84,256
-84,256
-82,638
-68,305
-43,283
Normalized EBITDA
-89,230
-89,230
-88,467
-68,806
-42,381
12/31/2021 - 1/7/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TRVI Trevi Therapeutics, Inc.
6.07
-0.49%
 
CGEM Cullinan Therapeutics, Inc.
7.89
+3.68%
 
CNTA Centessa Pharmaceuticals plc
12.30
+3.93%
 
OLMA Olema Pharmaceuticals, Inc.
4.4200
+3.76%
 
ALEC Alector, Inc.
0.9201
-5.95%
 
VYGR Voyager Therapeutics, Inc.
3.1600
+0.96%
 
CELC Celcuity Inc.
10.24
+2.50%
 
PEPG PepGen Inc.
1.3300
+8.13%
 
SRRK Scholar Rock Holding Corporation
30.75
+3.33%
 
BCYC Bicycle Therapeutics plc
7.39
-1.34%